Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-03

Clinical Trial Update: Influence of Cannabidiol on Glucose Tolerance and The Gut Microbiota [NA]

View source ↗

Summary

This completed clinical trial examined the effects of cannabidiol on glucose tolerance and the gut microbiota in individuals with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Christopher Bell | Conditions: Diabetes | NA | Status: COMPLETED